Clinical Trial Update: Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 study of the interaction between high-dose rifampicin and efavirenz in patients with pulmonary tuberculosis and HIV c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Rifampicin

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Tuberculosis, HIV | Phase 2 | Status: UNKNOWN